Increased expression of OCT4 is associated with low differentiation and tumor recurrence in human hepatocellular carcinoma

Pathology Research and Practice

Volumn 208, Issue 9, 2012, Pages 527-533

  Dong, Zhongyi ^a   Zeng, Qin ^a   Luo, Hesan ^a   Zou, Jinjin ^a   Cao, Chuanhui ^a   Liang, Jiyun ^a   Wu, Dehua ^a   Liu, Li ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Differentiation; Hepatocellular carcinoma; OCT4; Prognosis; Recurrence

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4;

ADULT; ARTICLE; CANCER PROGNOSIS; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECURRENCE RISK; TUMOR RECURRENCE; TUMOR VOLUME; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATECTOMY; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OCTAMER TRANSCRIPTION FACTOR-3; PROGNOSIS; RNA, MESSENGER; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84865303697     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2012.05.019     Document Type: Article

References (43)

1. Aravalli R.N., Steer C.J., Cressman E.N. Molecular mechanisms of hepatocellular carcinoma. Hepatology 2008, 48:2047-2063.
2. Andersen J.B., Loi R., Perra A., Factor V.M., Ledda-Columbano G.M., Columbano A., Thorgeirsson S.S. Progenitor-derived hepatocellular carcinoma model in the rat. Hepatology 2010, 51:1401-1409.
3. Fu J., Chen Y., Cao J., Luo T., Qian Y.W., Yang W., Ren Y.B., Su B., Cao G.W., Yang Y., Yan Y.Q., Shen F., Wu M.C., Feng G.S., Wang H.Y. p28(GANK) overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1alpha pathways. Hepatology 2011, 53:181-192.
4. Fujii T., Nomoto S., Koshikawa K., Yatabe Y., Teshigawara O., Mori T., Inoue S., Takeda S., Nakao A. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis. Hepatology 2006, 43:1267-1275.
5. Wang J.C., Dick J.E. Cancer stem cells: lessons from leukemia. Trends Cell Biol. 2005, 15:494-501.
6. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
7. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 2008, 8:755-768.
8. Teufel A., Galle P.R. Collecting evidence for a stem cell hypothesis in HCC. Gut 2010, 59:870-871.
9. Cheng L., Sung M.T., Cossu-Rocca P., Jones T.D., MacLennan G.T., De Jong J., Lopez-Beltran A., Montironi R., Looijenga L.H. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J. Pathol. 2007, 211:1-9.
10. Kim J.B., Greber B., Arauzo-Bravo M.J., Meyer J., Park K.I., Zaehres H., Scholer H.R. Direct reprogramming of human neural stem cells by OCT4. Nature 2009, 461:649-653.
11. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., Guenther M.G., Kumar R.M., Murray H.L., Jenner R.G., Gifford D.K., Melton D.A., Jaenisch R., Young R.A. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956.
12. Yuan P., Han J., Guo G., Orlov Y.L., Huss M., Loh Y.H., Yaw L.P., Robson P., Lim B., Ng H.H. Eset partners with Oct4 to restrict extraembryonic trophoblast lineage potential in embryonic stem cells. Genes Dev. 2009, 23:2507-2520.
13. Stefanovic S., Abboud N., Desilets S., Nury D., Cowan C., Puceat M. Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate. J. Cell Biol. 2009, 186:665-673.
14. Niwa H., Miyazaki J., Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 2000, 24:372-376.
15. Matin M.M., Walsh J.R., Gokhale P.J., Draper J.S., Bahrami A.R., Morton I., Moore H.D., Andrews P.W. Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells 2004, 22:659-668.
16. Rosner M.H., Vigano M.A., Ozato K., Timmons P.M., Poirier F., Rigby P.W., Staudt L.M. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 1990, 345:686-692.
17. Huang P., Qiu J., Li B., Hong J., Lu C., Wang L., Wang J., Hu Y., Jia W., Yuan Y. Role of Sox2 and Oct4 in predicting survival of hepatocelluar carcinoma patients after hepatectomy. Clin. Biochem. 2011, 44:582-589.
18. Ezeh U.I., Turek P.J., Reijo R.A., Clark A.T. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 2005, 104:2255-2265.
19. Atlasi Y., Mowla S.J., Ziaee S.A., Bahrami A.R. OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int. J. Cancer 2007, 120:1598-1602.
20. Liu C.G., Lu Y., Wang B.B., Zhang Y.J., Zhang R.S., Chen B., Xu H., Jin F., Lu P. Clinical implications of stem cell gene Oct-4 expression in breast cancer. Ann. Surg. 2011, 253:1165-1171.
21. Ge N., Lin H.X., Xiao X.S., Guo L., Xu H.M., Wang X., Jin T., Cai X.Y., Liang Y., Hu W.H., Kang T. Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma. J. Transl. Med. 2010, 8:94.
22. Chen Y.C., Hsu H.S., Chen Y.W., Tsai T.H., How C.K., Wang C.Y., Hung S.C., Chang Y.L., Tsai M.L., Lee Y.Y., Ku H.H., Chiou S.H. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS ONE 2008, 3:e2637.
23. Tang B., Yu F., Li P., Tong L., Duan X., Xie T., Wang X. A near-infrared neutral pH fluorescent probe for monitoring minor pH changes: imaging in living HepG2 and HL-7702 cells. J. Am. Chem. Soc. 2009, 131:3016-3023.
24. Wu D., Ding Y., Wang S., Zhang Q., Liu L. Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma. J. Pathol. 2008, 216:167-175.
25. Huang P., Qiu J., Li B., Hong J., Lu C., Wang L., Wang J., Hu Y., Jia W., Yuan Y. Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomy. Clin. Biochem. 2011, 44:582-589.
26. Jordan C.T., Guzman M.L., Noble M. Cancer stem cells. N. Engl. J. Med. 2006, 355:1253-1261.
27. Hansis C., Grifo J.A., Krey L.C. Oct-4 expression in inner cell mass and trophectoderm of human blastocysts. Mol. Hum. Reprod. 2000, 6:999-1004.
28. Hansis C., Tang Y.X., Grifo J.A., Krey L.C. Analysis of Oct-4 expression and ploidy in individual human blastomeres. Mol. Hum. Reprod. 2001, 7:155-161.
29. Gidekel S., Pizov G., Bergman Y., Pikarsky E. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 2003, 4:361-370.
30. Zhou X., Huang G.R., Hu P. Over-expression of Oct4 in human esophageal squamous cell carcinoma. Mol. Cells 2011, 32:39-45.
31. Huang P., Chen J., Wang L., Na Y., Kaku H., Ueki H., Sasaki K., Yamaguchi K., Zhang K., Saika T., Nasu Y., Watanabe M., Kumon H. Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence. Med. Oncol. 2012, 29:829-834.
32. Liu C.G., Lu Y., Wang B.B., Zhang Y.J., Zhang R.S., Chen B., Xu H., Jin F., Lu P. Clinical implications of stem cell gene Oct-4 expression in breast cancer. Ann. Surg. 2011, 253:1165-1171.
33. Wen J., Park J.Y., Park K.H., Chung H.W., Bang S., Park S.W., Song S.Y. Oct4 and Nanog expression is associated with early stages of pancreatic carcinogenesis. Pancreas 2010, 39:622-626.
34. Yuan F., Zhou W., Zou C., Zhang Z., Hu H., Dai Z., Zhang Y. Expression of Oct4 in HCC and modulation to wnt/beta-catenin and TGF-beta signal pathways. Mol. Cell. Biochem. 2010, 343:155-162.
35. Oliva J., French B.A., Qing X., French S.W. The identification of stem cells in human liver diseases and hepatocellular carcinoma. Exp. Mol. Pathol. 2010, 88:331-340.
36. Nakagawa E., Zhang L., Kim E.J., Shin J.O., Cho S.W., Ohshima H., Jung H.S. The novel function of Oct3/4 in mouse tooth development. Histochem. Cell Biol. 2012, 137:367-376.
37. Young J.C., Major A.T., Miyamoto Y., Loveland K.L., Jans D.A. Distinct effects of importin alpha2 and alpha4 on Oct3/4 localization and expression in mouse embryonic stem cells. FASEB J. 2011, 25:3958-3965.
38. Chen R., Cui J., Xu C., Xue T., Guo K., Gao D., Liu Y., Ye S., Ren Z. The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection. Ann. Surg. Oncol. 2011, Jun 17 (Epub ahead of print).
39. Teufel A., Marquardt J.U., Galle P.R. Novel insights in the genetics of HCC recurrence and advances in transcriptomic data integration. J. Hepatol. 2012, 56:279-281.
40. Blendis L., Wong F. A marker for predictions of HCC recurrence postresection?. Gastroenterology 2002, 123:2152-2153.
41. Toyoda H., Kumada T., Kaneoka Y., Osaki Y., Kimura T., Arimoto A., Oka H., Yamazaki O., Manabe T., Urano F., Chung H., Kudo M., Matsunaga T. Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC. J. Hepatol. 2008, 49:223-232.
42. Morrison S.J., Shah N.M., Anderson D.J. Regulatory mechanisms in stem cell biology. Cell 1997, 88:287-298.
43. Abiko K., Mandai M., Hamanishi J., Matsumura N., Baba T., Horiuchi A., Mikami Y., Yoshioka S., Wakasa T., Shiozawa T., Konishi I. Oct4 expression in immature teratoma of the ovary: relevance to histologic grade and degree of differentiation. Am. J. Surg. Pathol. 2010, 34:1842-1848.